Pharmacist’s Application to Practice: Talquetamab-tgvs
August 09, 2023
Marguerite Courtney, PharmD Candidate 2024 and Bradley Yelvington, PharmD, BCOP from University of Tennessee discuss talquetamab-tgvs
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Epcoritamab-bysp
May 19, 2023
Shaniya Pleasant, PharmD/MHCI Candidate and Bradley Yelvington, PharmD, BCOP from Vanderbilt University Medical Center write about epcoritamab-bysp
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Retifanlimab-dlwr
March 22, 2023
Bernard Marini, PharmD, BCOP, Clinical Pharmacist Specialist at University of Michigan College of Pharmacy writes about Retifanlimab-dlwr.
Drug Updates
Pharmacist’s Application to Practice: Elacestrant
January 27, 2023
Monica Chintapenta, PharmD, BCOP, Pharmacist Clinical Specialist at Parkland Health and Hospital Systems writes about Elacestrant
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Pirtobrutinib
January 27, 2023
Andy Hawn, 2025 PharmD Candidate and Erin Kelley, PharmD, BCOP at the Masonic Cancer Clinic Infusion Pharmacy write about Pirtobrutinib
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Mosunetuzumab
December 22, 2022
Bernard Marini, PharmD, BCOP Clinical Pharmacist Specialist – Hematology/Oncology Clinical Associate Professor University of Michigan College of Pharmacy writes about Mosunetuzumab.
Tools and Resources
Drug Updates
Pharmacist Application to Practice: Adagrasib
December 22, 2022
Sam Palmatier, Pharmacy Intern and Jeff Engle, PharmD, MS, Oncology Pharmacy Manager at Fairview Cancer Clinic – Edina write about
Drug Updates
Pharmacist's Application to Practice: Nadofaragene firadenovec-vncg
December 16, 2022
Kelli Rourke, PharmD Clinical Pharmacy Specialist at The Johns Hopkins Hospital writes about nadofaragene firadenovec-vncg
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Olutasidenib
December 01, 2022
Bernard Marini, PharmD, BCOP, Clinical Pharmacist at University of Michigan College of Pharmacy writes about Olutasidenib
Drug Updates
Pharmacist’s Application to Practice: Mirvetuximab soravtansine-gynx
November 14, 2022
Shrina Patel, PharmD, BCOP, Clinical Pharmacy Specialist at University of Texas MD Anderson Cancer Center writes about Mirvetuximab soravtansine-gynx.
Tools and Resources
Drug Updates
Pharmacist's Application to Practice: Tremelimumab
November 10, 2022
Tremelimumab (IMJUDO, AztraZeneca Pharmaceuticals) approved November 10, 2022 for metastatic non-small cell lung cancer and approved October 24, 2022 for unresectable hepatocellular carcinoma
Tools and Resources
Drug Updates
Pharmacist’s Application to Practice: Teclistamab-cqyv
October 25, 2022
Gavyn Walsh, PD3 Oncology Pharmacy Intern and Erin Kelley, PharmD, BCOP at M Health Fairview Masonic Cancer Clinic write about teclistamab-cqyv
Clear filter
